Roche has signed a development and collaboration agreement with Novo Nordisk, a leader in innovating the therapy of diabetes and obesity. Under the terms of the development and collaboration agreement, the partners will integrate insulin data from Novo Nordisk's connected pen to Roche's open ecosystem, synchronizing with its suite of digital diabetes management solutions including mySugr.People with diabetes spend an average of one hour per day on self-care and have to make up to 50 therapy
Read More
Novo Nordisk
Novo Nordisk Launches the Innovation Challenge Focused on Diabetes Management
Novo Nordisk, a global leader in the diabetes space, is seizing the opportunity to advance care and leverage digital health technology through the Novo Nordisk Innovation Challenge. With support from MATTER, a prominent incubator and innovation hub, Novo Nordisk is challenging start-ups, researchers, entrepreneurs, and students to explore, design; and co-develop digital health solutions for the more than 400 million people living with diabetes worldwide.The first phase of the challenge is
Read More
Novo Nordisk, Sempre Health Launch Pilot to Improve Medication Costs for Diabetic Patients
Sempre Health, a solution for behavior-based healthcare pricing has announced a pilot program with Novo Nordisk to add diabetes medications to the Sempre Health’s affordability & engagement solution. Unlike traditional coupons and vouchers, Sempre works with health plans to reward their membership’s positive choices and actions. For example, a patient may earn a lower copay if she fills her prescription on time. The two companies are seeking to engage 10,000 patients with diabetes on the
Read More
Novo Nordisk, HITLAB Launches $75k Challenge to Develop Voice-Activated Technology for Diabetes Care
Novo Nordisk has teamed up with HITLAB (Health Innovation Technology Lab, Inc.) to launch the 2017 HITLAB World Cup of Voice-Activated Technology in Diabetes presented by Novo Nordisk awarding prizes totaling $75,000. Managing diabetes requires strict adherence to dietary, physical activity, and medication protocols. For people living with diabetes, voice-activated technologies are an important way they can manage their disease. Innovators should focus on enhancing patient outcomes, lowering
Read More
Novo Nordisk & Glooko Launch Integrated Diabetes Management App
Novo Nordisk and Glooko has announced the launch of their new integrated diabetes management app, Cornerstones4Care (C4C app) for patients. The C4C mobile app integrates Novo Nordisk's extensive knowledge of diabetes and personalized patient support with Glooko's digital platform and data analytics expertise. Cornerstones4Care Powered by Glooko AppThe integrated app concept will initially enable people with diabetes to easily measure and track their blood glucose, activity and meals all in one
Read More
Novo Nordisk, Glooko Team Up to Develop Digital Diabetes Solutions
Pharmaceutical company Novo Nordisk and Glooko, a remote patient monitoring platform for diabetes are teaming up to develop digital health solutions for diabetes. As part of the non-exclusive collaboration, both companies will work together to create co-branded digital health solutions that will deliver personalized, digital services to support people with diabetes in areas including treatment adherence and blood glucose management.For Novo Nordisk, the integration of these offerings within its
Read More